David Köhler
Impact in
Papers in
- Co-authors
- Barry R. Goldspiel (10 shared papers)Seth M. Steinberg (11 shared papers)Elaine S. Jaffe (4 shared papers)R. Wittes (3 shared papers)Donna Headlee (6 shared papers)A Tompkins (3 shared papers)William D. Figg (5 shared papers)Wyndham H. Wilson (3 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Inflammatory Bowel Diseases (2 papers)Polymer Degradation and Stability (2 papers)Annals of Oncology (2 papers)American Journal of Health-System Pharmacy (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
David Köhler
59 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 146
- Neurology 364
- Oncology 641
- Pathology and Forensic Medicine 372
- Genetics 215
- Cancer Research 270
Countries citing papers authored by David Köhler
This map shows the geographic impact of David Köhler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Köhler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Köhler more than expected).
Fields of papers citing papers by David Köhler
This network shows the impact of papers produced by David Köhler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Köhler. The network helps show where David Köhler may publish in the future.
Co-authors
The 25 scholars most cited alongside David Köhler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer. | 2001 | 242 |
| 2 | 2000 | 217 | |
| 3 | 1993 | 202 | |
| 4 | 1998 | 173 | |
| 5 | 2001 | 129 | |
| 6 | 1995 | 110 | |
| 7 | 1999 | 98 | |
| 8 | 2002 | 96 | |
| 9 | A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma. | 2000 | 92 |
| 10 | 1994 | 83 | |
| 11 | 1995 | 79 | |
| 12 | A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer. | 1999 | 79 |
| 13 | Transdermally administered fentanyl for pain management. | 1992 | 65 |
| 14 | 1994 | 58 | |
| 15 | 2020 | 54 | |
| 16 | 1990 | 53 | |
| 17 | 1996 | 44 | |
| 18 | 1995 | 40 | |
| 19 | 1992 | 38 | |
| 20 | 2011 | 37 |
About David Köhler
David Köhler is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 63 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Prostate Cancer Treatment and Research (6 papers), Estrogen and related hormone effects (5 papers), Inflammatory Bowel Disease (5 papers), Hormonal and reproductive studies (3 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Nutrition and Health in Aging (3 papers) and Pharmacy and Medical Practices (3 papers). The work is most often cited by research in Neurology (364 citations), Oncology (641 citations), Pathology and Forensic Medicine (372 citations), Genetics (215 citations) and Cancer Research (270 citations). David Köhler has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Barry R. Goldspiel, Seth M. Steinberg, Elaine S. Jaffe, R. Wittes, Donna Headlee, A Tompkins, William D. Figg, Wyndham H. Wilson, James M. Pluda and G Bryant. Their work appears in journals such as Journal of Clinical Oncology, Inflammatory Bowel Diseases, Polymer Degradation and Stability, Annals of Oncology and American Journal of Health-System Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.